A pivotal phase II trial for CYTO-NK-201
Latest Information Update: 17 Mar 2021
At a glance
- Drugs CYTO NK 201 (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
Most Recent Events
- 17 Mar 2021 New trial record
Latest Information Update: 17 Mar 2021